A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms



Status:Archived
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2010
End Date:March 2012

Use our guide to learn which trials are right for you!

A 17-Week, Phase 2, Multicenter, Randomized, Double-Blind Study of Treatment With LY2140023 Combined With Standard of Care Compared to Placebo Combined With Standard of Care in the Treatment of Patients With Prominent Negative Symptoms of Schizophrenia


The purpose of this study is to determine whether LY2140023, when added to standard-of-care
antipsychotic treatment, will improve negative symptoms.



We found this trial at
9
sites
?
mi
from
Topeka, KS
Click here to add this to my saved trials
1 South Prospect Street
Burlington, Vermont 05401
802-656-8990
?
mi
from
Burlington, VT
Click here to add this to my saved trials
100 Campus Dr # 108
Scarborough, Maine 04074
(207) 396-7600
Maine Center for Cancer Medicine and Blood Disorders - Scarborough Maine Center for Cancer Medicine...
?
mi
from
Scarborough, ME
Click here to add this to my saved trials
?
mi
from
Alexandria, LA
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Washington, Washington DC 20422
?
mi
from
Washington, DC
Click here to add this to my saved trials